Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 15;193(11):E380.
doi: 10.1503/cmaj.78144.

Life expectancy in patients with inflammatory bowel disease: time will tell if biologics are the answer

Neil Chanchlani  1 , Richard K Russell  2
Affiliations
Comment

Life expectancy in patients with inflammatory bowel disease: time will tell if biologics are the answer

Neil Chanchlani et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Neil Chanchlani is an associate editor for CMAJ and was not involved in the editorial decision-making process for this article. Richard Russell declares an NHS Research Scotland Senior Research Fellowship and speaker fees, travel support or participation in medical board meetings with Nestlé, AbbVie, Dr. Falk Pharma, Takeda, Napp, Mead Johnson, Nutricia and 4D Pharma. No other competing interests were declared.

Comment on

Similar articles

See all similar articles

References

    1. Kuenzig ME, Manuel DG, Donelle J, et al. . Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease. CMAJ 2020;192:E1394–402. - PMC - PubMed
    1. Olén O, Askling J, Sachs MC, et al. . Increased mortality of patients with childhood-onset inflammatory bowel diseases, compared with the general population. Gastroenterology 2019;156:614–22. - PubMed
    1. Ng SC, Shi HY, Hamidi N, et al. . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2018;390: 2769–78. - PubMed
    1. Targownik LE, Tennakoon A, Leung S, et al. . Temporal trends in initiation of therapy with tumor necrosis factor antagonists for patients with inflammatory bowel disease: a population-based analysis. Clin Gastroenterol Hepatol 2017;15:1061–1070.e1. - PubMed
    1. Ashton JJ, Borca F, Mossotto E, et al. . Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood. Aliment Pharmacol Ther 2019;49:398–407. - PubMed

MeSH terms

Substances